Ultragenyx Pharmaceutical said on Monday that late-stage studies showed its drug for a type of genetic bone disease failed to ...

A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine at the University of ...

Ultragenyx is developing setrusumab in pediatric and young adult patients across OI sub-types I, III and IV with two late-stage studies: the pivotal Phase 2/3 Orbit study and Phase 3 Cosmic study.

Tea and coffee are two of the most popular drinks in the world – daily rituals linked to culture, comfort, and productivity.

Ultragenyx Pharmaceutical said on Monday late-stage studies showed its experimental drug for a type of genetic bone disease failed to reduce the number of fractures that occurred per year. Shares of ...

Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (ORBIT) or bisphosphonates ...

Setrusumab is a monoclonal antibody that inhibits sclerostin, a protein that negatively regulates bone development, allowing for new bone formation.

Taking omega-3 and vitamin D supplements together may help reduce pain, slow biological aging, improve bone health, and help ...

Learn how fossils form through sedimentation and mineralization. Discover types like moulds, casts, and trace fossils in our ...

Nowadays, comic book fans have countless superhero shows to choose from. Let's try to choose the 15 best, the best of the ...

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...

Four mice launched on October 31 via the Shenzhou-21 crewed mission, housed in a specialised habitat designed to mimic Earth ...